These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38189762)

  • 21. Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies - Developing Potential Treatments for the Entire Spectrum of Disease.
    McDonald C; Camino E; Escandon R; Finkel RS; Fischer R; Flanigan K; Furlong P; Juhasz R; Martin AS; Villa C; Sweeney HL
    J Neuromuscul Dis; 2024; 11(2):499-523. PubMed ID: 38363616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for Duchenne muscular dystrophy in Germany, 1977-2011: A personal story.
    Scheuerbrandt G
    Muscle Nerve; 2018 Feb; 57(2):185-188. PubMed ID: 28981144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic diagnosis as a tool for personalized treatment of Duchenne muscular dystrophy.
    Bello L; Pegoraro E
    Acta Myol; 2016 Dec; 35(3):122-127. PubMed ID: 28484312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy.
    Farrar MA; Kariyawasam D; Grattan S; Bayley K; Davis M; Holland S; Waddel LB; Jones K; Lorentzos M; Ravine A; Wotton T; Wiley V;
    J Neuromuscul Dis; 2023; 10(1):15-28. PubMed ID: 36373292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Genetic analysis and prenatal diagnosis of Duchenne or Becker muscular dystrophy].
    Zhao W; Jiang N; Li S; Li JS; Miao Y; Liang SY; Yu DY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):226-231. PubMed ID: 31006187
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic analysis of 62 Chinese families with Duchenne muscular dystrophy and strategies of prenatal diagnosis in a single center.
    Zhang J; Ma D; Liu G; Wang Y; Liu A; Li L; Luo C; Hu P; Xu Z
    BMC Med Genet; 2019 Nov; 20(1):180. PubMed ID: 31727011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of genetic diagnosis for Duchenne muscular dystrophy.
    Aartsma-Rus A; Ginjaar IB; Bushby K
    J Med Genet; 2016 Mar; 53(3):145-51. PubMed ID: 26754139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for conditions that do not meet the Wilson and Jungner criteria: the case of Duchenne muscular dystrophy.
    Ross LF
    Am J Med Genet A; 2006 Apr; 140(8):914-22. PubMed ID: 16528755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving recognition of Duchenne muscular dystrophy: a retrospective case note review.
    van Ruiten HJ; Straub V; Bushby K; Guglieri M
    Arch Dis Child; 2014 Dec; 99(12):1074-7. PubMed ID: 25187493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).
    Ciafaloni E; Fox DJ; Pandya S; Westfield CP; Puzhankara S; Romitti PA; Mathews KD; Miller TM; Matthews DJ; Miller LA; Cunniff C; Druschel CM; Moxley RT
    J Pediatr; 2009 Sep; 155(3):380-5. PubMed ID: 19394035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical practice guidelines for Duchenne muscular dystrophy].
    Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association ; Tan H; Liang D; Wu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Mar; 37(3):258-262. PubMed ID: 32128741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic analysis of 1051 Chinese families with Duchenne/Becker Muscular Dystrophy.
    Kong X; Zhong X; Liu L; Cui S; Yang Y; Kong L
    BMC Med Genet; 2019 Aug; 20(1):139. PubMed ID: 31412794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliability and validity of the Thai version of the Pediatric Quality of Life inventory™ 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy.
    Thongsing A; Likasitwattanakul S; Sanmaneechai O
    Health Qual Life Outcomes; 2019 May; 17(1):76. PubMed ID: 31046775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan.
    Chien YH; Lee NC; Weng WC; Chen LC; Huang YH; Wu CS; Hwu WL
    Neurol Sci; 2022 Jul; 43(7):4563-4566. PubMed ID: 35562557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newborn screening and genomic analysis of duchenne muscular dystrophy in Henan, China.
    Jia C; Zhao D; Li Y; Gao Y; Zhang X; Li X; Lv S; Li R; Zhu X; Liu S
    Clin Chim Acta; 2023 Jan; 539():90-96. PubMed ID: 36516925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticosteroids for the treatment of Duchenne muscular dystrophy.
    Matthews E; Brassington R; Kuntzer T; Jichi F; Manzur AY
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD003725. PubMed ID: 27149418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
    Echigoya Y; Lim KRQ; Trieu N; Bao B; Miskew Nichols B; Vila MC; Novak JS; Hara Y; Lee J; Touznik A; Mamchaoui K; Aoki Y; Takeda S; Nagaraju K; Mouly V; Maruyama R; Duddy W; Yokota T
    Mol Ther; 2017 Nov; 25(11):2561-2572. PubMed ID: 28865998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duchenne muscular dystrophy: a 30-year population-based incidence study.
    Dooley J; Gordon KE; Dodds L; MacSween J
    Clin Pediatr (Phila); 2010 Feb; 49(2):177-9. PubMed ID: 20080524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy.
    Dzierlega K; Yokota T
    Gene Ther; 2020 Sep; 27(9):407-416. PubMed ID: 32483212
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.